Replies to post #15786 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

55

My Reply would be.

WTH? SCLC/Tumors, IPF/CC, Stroke. Nasdaq IPO...Seems like a full hand for some time, IMO. Financing proxy is conditional on the Nasdaq move. AGN could make a Nice Big Splash with those IPO cards, IMO.

55

AGN plans an up-list AFTER news about significant progress in one or more of it's current initiatives.
The size and price will be determined by the magnitude and future possibilities presented in relation as to what the market will accept/support.

Those are conflicting statement.

You have now s h I f t e d your claim/belief that there will be no financing until AFTER 1 or more clinical trials report positive data that will move the needle/share price significantly BEFORE a financing of any sort (Fire Sale Private Placement or Fire Sale IPO). It's impossible to have any type of legitimate debate if one is consistently shifting their position as if it was never expressed and just moves on like it never happened. Bottom line is there will be a financing regardless to an uplist because they need the money to conduct whatever Phase 1/2 studies in the pipeline for 2022/2023. Debating over known facts is one thing. Debating over fiction is completely bonkers.

Have @ !t

MS